Aetion and McKesson today announced a strategic collaboration to advance the use of real world evidence in cancer research – offering joint solutions to support the FDA’s demonstration project and commercial customers.
Aetion today announced that former FDA Commissioner Scott Gottlieb has joined its board of directors to help to advance the use of RWE in drug development and commercialization.